10.21147/j.issn.1000-9604.2022.03.05
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China(English version)
Contents
1.Introduction
2.Diagnostic techniques and applications
2.1 Risk factors for pancreatic cancer
2.2 Clinical manifestations
2.3 Physical examination
2.4 Radiological examination
2.4.1 Ultrasound
2.4.2 Computed tomography(CT)
2.4.3 Magnetic resonance imaging(MRI)and magnetic resonance cholangiopancreatography(MRCP)
2.4.4 Positron emission tomography-CT(PET-CT)
2.4.5 Endoscopic ultrasonography(EUS)
2.4.6 Role of ERCP in diagnosis of pancreatic cancer
2.4.7 Bone scans
2.5 Blood immunologic and biochemical examinations
2.5.1 Blood biochemical examination
2.5.2 Serum tumor markers
2.6 Histologic and cytological diagnosis
2.6.1 Cytological pathology diagnosis
2.6.2 Histopathology diagnosis of pancreatic cancer
2.6.3 Immunohistochemistry
2.6.4 Pathologic reports of pancreatic cancer
2.7 Differential diagnosis of pancreatic cancer
2.7.1 Chronic pancreatitis
2.7.2 Carcinoma of ampulla
2.7.3 Pancreatic cystadenoma and cystadenocarcinoma
2.7.4 Choledocholithiasis
2.7.5 Other lesions of pancreas
3.Classification and staging of pancreatic cancer
3.1 Histologic classification of pancreatic cancer
3.2 Staging of pancreatic cancer(AJCC,the 8th edition)
3.2.1 Definition ofT,N and M in pancreatic TNM staging
3.2.2 TNM staging for pancreatic cancer
national、english、cancer、china、diagnosis、guidelines、pancreatic、treatment、version
34
S;H313;G2
2022-08-09(万方平台首次上网日期,不代表论文的发表时间)
共18页
238-255